Compounds > irinotecan

Page last updated: 2024-08-24

irinotecan and Dysarthosis

irinotecan has been researched along with Dysarthosis in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (40.00)	29.6817
2010's	5 (50.00)	24.3611
2020's	1 (10.00)	2.80

Authors

Authors	Studies
Elbeddini, A; Gazarin, M; Hooda, N; McMillan, J; Webster, P	1
McDevitt, RL; Sahai, V; Zalupski, MM; Zhen, DB	1
Ahn, JH; Kang, HW; Kim, H; Lee, KA; Suk, HJ	1
Dasanu, CA; Joseph, R	1
Edenfield, WJ; Koch, MD; Ramirez, KG	1
Asaka, M; Fukushima, H; Iwanaga, I; Kawamoto, Y; Kobayashi, Y; Komatsu, Y; Nakatsumi, H; Sasaki, T; Sogabe, S; Takano, H; Uehata, Y; Yuki, S	1
Bègue, M; Ceccaldi, B; Hauteville, D; Kara, F; Le Marec, E; Mommeja-Marin, H; Saint Blancard, P	1
Bertagnolio, MF; De Marco, S; Squilloni, E; Sternberg, CN; Vigna, L	1
Brandsma, D; De Jong, FA; Hamberg, P; Sleijfer, S; Verweij, J	1
Baz, DV; Bofill, JS; Nogueira, JA	1

Reviews

3 review(s) available for irinotecan and Dysarthosis

Article	Year
[A case of sigmoid colon cancer with temporary dysarthria associated with irinotecan]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:8 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Dysarthria; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Sigmoid Neoplasms	2011
Irinotecan-induced central nervous system toxicity. Report on two cases and review of the literature. Acta oncologica (Stockholm, Sweden), 2008, Volume: 47, Issue:5 Topics: Adult; Antiemetics; Antineoplastic Agents, Phytogenic; Ataxia; Camptothecin; Capecitabine; Central Nervous System; Colorectal Neoplasms; Cytotoxins; Deoxycytidine; Dexamethasone; Dysarthria; Female; Fluorouracil; Granisetron; Humans; Irinotecan; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Sarcoma, Small Cell; Serotonin Antagonists; Topoisomerase I Inhibitors	2008
Irinotecan-induced dysarthria. Journal of the National Cancer Institute, 2001, Sep-19, Volume: 93, Issue:18 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Aphasia, Broca; Bone Neoplasms; Camptothecin; Dysarthria; Enzyme Inhibitors; Fatal Outcome; Female; Fluorouracil; Humans; Infusions, Intravenous; Irinotecan; Lung Neoplasms; Magnetic Resonance Imaging; Organoplatinum Compounds; Oxaliplatin; Premedication; Sigmoid Neoplasms	2001

Other Studies

7 other study(ies) available for irinotecan and Dysarthosis

Article	Year
Irinotecan-Associated Dysarthria in Patients with Pancreatic Cancer: A Single Site Experience. The American journal of case reports, 2020, Jun-28, Volume: 21 Topics: Aged; Dysarthria; Female; Humans; Irinotecan; Middle Aged; Pancreatic Neoplasms; Topoisomerase I Inhibitors	2020
Irinotecan-associated dysarthria: A single institution case series with management implications in patients with gastrointestinal malignancies. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019, Volume: 25, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dysarthria; Female; Gastrointestinal Neoplasms; Humans; Irinotecan; Male; Middle Aged; Topoisomerase I Inhibitors	2019
Dysarthria induced by irinotecan in a patient with colorectal cancer. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2013, Jul-01, Volume: 70, Issue:13 Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Dose-Response Relationship, Drug; Dysarthria; Humans; Infusion Pumps; Irinotecan; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Sigmoid Neoplasms; Treatment Failure; Treatment Outcome	2013
A curious case of oxaliplatin-induced neurotoxicity: recurrent, self-limiting dysarthria. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2014, Volume: 20, Issue:5 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administration Schedule; Dysarthria; Fluorouracil; Humans; Irinotecan; Leucovorin; Male; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Recurrence; Time Factors	2014
Irinotecan-induced dysarthria: A case report and review of the literature. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2017, Volume: 23, Issue:3 Topics: Adult; Camptothecin; Colorectal Neoplasms; Drug Administration Schedule; Dysarthria; Female; Humans; Irinotecan	2017
[Dysarthria during irinotecan administration]. La Revue de medecine interne, 2002, Volume: 23, Issue:11 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Phytogenic; Camptothecin; Diagnosis, Differential; Dysarthria; Endometrial Neoplasms; Female; Humans; Irinotecan; Magnetic Resonance Imaging	2002
Irinotecan chemotherapy associated with transient dysarthria and aphasia. Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:7 Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Aphasia; Camptothecin; Colonic Neoplasms; Dysarthria; Fluorouracil; Humans; Infusion Pumps; Irinotecan; Male	2004